Insulinoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
(11 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Insulinoma}} | {{Insulinoma}} | ||
{{CMG}}; {{AE}} {{ADS}} | |||
==Overview== | |||
There is insufficient evidence to recommend routine screening for insulinoma. | |||
==Screening== | |||
*There is insufficient evidence to recommend routine screening for insulinoma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
[[Category: | {{WS}} | ||
| |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] |
Latest revision as of 22:25, 29 July 2020
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma screening On the Web |
American Roentgen Ray Society Images of Insulinoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for insulinoma.
Screening
- There is insufficient evidence to recommend routine screening for insulinoma.
References